Droloxifene
Droloxifene
Droloxifene (pronounced: dro-lox-i-fene) is a Selective Estrogen Receptor Modulator (SERM) that is primarily used in the treatment of breast cancer. It is similar in function to tamoxifen, but has been found to have fewer side effects.
Etymology
The term "Droloxifene" is derived from the chemical name 2-(p-((Z)-4-Droloxyphenyl)-1,2-diphenyl-1-buten-1-yl)phenoxy)-N,N-dimethylethanamine. The prefix "Drolo" refers to the droloxyphenyl group in the chemical structure, while "xifene" is a common suffix used for drugs that act as estrogen receptor modulators.
Usage
Droloxifene is used primarily in the treatment of estrogen receptor-positive breast cancer. It works by binding to the estrogen receptors in the cancer cells, thereby blocking the effects of estrogen and slowing the growth of the cancer.
Related Terms
- Selective Estrogen Receptor Modulator (SERM): A type of drug that acts on the estrogen receptors in the body. SERMs can either block or activate the effects of estrogen, depending on the specific tissue.
- Breast Cancer: A type of cancer that forms in the cells of the breasts. It is the most common cancer in women worldwide.
- Tamoxifen: A SERM that is commonly used in the treatment of breast cancer. It is similar in function to droloxifene, but has been found to have more side effects.
See Also
External links
- Medical encyclopedia article on Droloxifene
- Wikipedia's article - Droloxifene
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski